BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22298786)

  • 1. Role of metalloproteases in vaccinia virus epitope processing for transporter associated with antigen processing (TAP)-independent human leukocyte antigen (HLA)-B7 class I antigen presentation.
    Lorente E; García R; Mir C; Barriga A; Lemonnier FA; Ramos M; López D
    J Biol Chem; 2012 Mar; 287(13):9990-10000. PubMed ID: 22298786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and immunological remarks about TAP deficiency.
    Zimmer J; Sleiman M; Hentges F; Gadola SD
    J Biol Chem; 2012 Aug; 287(32):27047; author reply 27048. PubMed ID: 22865894
    [No Abstract]   [Full Text] [Related]  

  • 3. A viral, transporter associated with antigen processing (TAP)-independent, high affinity ligand with alternative interactions endogenously presented by the nonclassical human leukocyte antigen E class I molecule.
    Lorente E; Infantes S; Abia D; Barnea E; Beer I; García R; Lasala F; Jiménez M; Mir C; Morreale A; Admon A; López D
    J Biol Chem; 2012 Oct; 287(42):34895-34903. PubMed ID: 22927436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple viral ligands naturally presented by different class I molecules in transporter antigen processing-deficient vaccinia virus-infected cells.
    Lorente E; Infantes S; Barnea E; Beer I; García R; Lasala F; Jiménez M; Vilches C; Lemonnier FA; Admon A; López D
    J Virol; 2012 Jan; 86(1):527-41. PubMed ID: 22031944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transporter (TAP)-independent processing of a multiple membrane-spanning protein, the Epstein-Barr virus latent membrane protein 2.
    Lee SP; Thomas WA; Blake NW; Rickinson AB
    Eur J Immunol; 1996 Aug; 26(8):1875-83. PubMed ID: 8765034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8(+) T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway.
    Lautscham G; Mayrhofer S; Taylor G; Haigh T; Leese A; Rickinson A; Blake N
    J Exp Med; 2001 Oct; 194(8):1053-68. PubMed ID: 11602636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of vaccinia CD8+ T-cell epitopes conserved among vaccinia and variola viruses restricted by common MHC class I molecules, HLA-A2 or HLA-B7.
    Terajima M; Cruz J; Leporati AM; Demkowicz WE; Kennedy JS; Ennis FA
    Hum Immunol; 2006 Jul; 67(7):512-20. PubMed ID: 16829305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing vaccinia virus class-I epitopes presentation by HSV-ICP47 enhances the immunogenicity of a TAP-independent cancer vaccine epitope.
    Raafat N; Sadowski-Cron C; Mengus C; Heberer M; Spagnoli GC; Zajac P
    Int J Cancer; 2012 Sep; 131(5):E659-69. PubMed ID: 22116674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allele-dependent processing pathways generate the endogenous human leukocyte antigen (HLA) class I peptide repertoire in transporters associated with antigen processing (TAP)-deficient cells.
    Lorente E; García R; López D
    J Biol Chem; 2011 Nov; 286(44):38054-38059. PubMed ID: 21914809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple antigen-specific processing pathways for activating naive CD8+ T cells in vivo.
    Norbury CC; Princiotta MF; Bacik I; Brutkiewicz RR; Wood P; Elliott T; Bennink JR; Yewdell JW
    J Immunol; 2001 Apr; 166(7):4355-62. PubMed ID: 11254689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination and the TAP-independent antigen processing pathways.
    López D; Lorente E; Barriga A; Johnstone C; Mir C
    Expert Rev Vaccines; 2013 Sep; 12(9):1077-83. PubMed ID: 24053400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity of natural self-derived ligands presented by different HLA class I molecules in transporter antigen processing-deficient cells.
    Lorente E; Infantes S; Barnea E; Beer I; Barriga A; García-Medel N; Lasala F; Jiménez M; Admon A; López D
    PLoS One; 2013; 8(3):e59118. PubMed ID: 23555621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two novel routes of transporter associated with antigen processing (TAP)-independent major histocompatibility complex class I antigen processing.
    Snyder HL; Bacík I; Bennink JR; Kearns G; Behrens TW; Bächi T; Orlowski M; Yewdell JW
    J Exp Med; 1997 Oct; 186(7):1087-98. PubMed ID: 9314557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccinia virus-specific CD8(+) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans.
    Terajima M; Orphin L; Leporati AM; Pazoles P; Cruz J; Rothman AL; Ennis FA
    Hum Immunol; 2008 Dec; 69(12):815-25. PubMed ID: 18955096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An epitope-selective, transporter associated with antigen presentation (TAP)-1/2-independent pathway and a more general TAP-1/2-dependent antigen-processing pathway allow recognition of the HIV-1 envelope glycoprotein by CD8+ CTL.
    Hammond SA; Johnson RP; Kalams SA; Walker BD; Takiguchi M; Safrit JT; Koup RA; Siliciano RF
    J Immunol; 1995 Jun; 154(11):6140-56. PubMed ID: 7538543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspases in virus-infected cells contribute to recognition by CD8+ T lymphocytes.
    López D; García-Calvo M; Smith GL; Del Val M
    J Immunol; 2010 May; 184(9):5193-9. PubMed ID: 20348426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentation of endogenously synthesized MHC class II-restricted epitopes by MHC class II cancer vaccines is independent of transporter associated with Ag processing and the proteasome.
    Dissanayake SK; Tuera N; Ostrand-Rosenberg S
    J Immunol; 2005 Feb; 174(4):1811-9. PubMed ID: 15699107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term immunity against actual poxviral HLA ligands as identified by differential stable isotope labeling.
    Meyer VS; Kastenmuller W; Gasteiger G; Franz-Wachtel M; Lamkemeyer T; Rammensee HG; Stevanovic S; Sigurdardottir D; Drexler I
    J Immunol; 2008 Nov; 181(9):6371-83. PubMed ID: 18941228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules.
    Bai A; Forman J
    J Immunol; 1997 Sep; 159(5):2139-46. PubMed ID: 9278300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a proteasome and TAP-independent presentation of intracellular epitopes by HLA-B27 molecules.
    Magnacca A; Persiconi I; Nurzia E; Caristi S; Meloni F; Barnaba V; Paladini F; Raimondo D; Fiorillo MT; Sorrentino R
    J Biol Chem; 2012 Aug; 287(36):30358-67. PubMed ID: 22807446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.